Geode Capital Management, LLC Pds Biotechnology Corp Transaction History

Geode Capital Management, LLC

  • $1.21 Trillion
  • Q3 2024

A detailed history of Geode Capital Management, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 415,113 shares of PDSB stock, worth $813,621. This represents 0.0% of its overall portfolio holdings.

Number of Shares
415,113
Previous 377,971 9.83%
Holding current value
$813,621
Previous $1.11 Million 43.18%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$2.93 - $4.23 $108,826 - $157,110
37,142 Added 9.83%
415,113 $1.59 Million
Q2 2024

Aug 09, 2024
SELL
$2.55 - $4.02 $704,345 - $1.11 Million
-276,214 Reduced 42.22%
377,971 $1.11 Million
Q1 2024

May 13, 2024
BUY
$3.85 - $6.59 $80,776 - $138,264
20,981 Added 3.31%
654,185 $2.59 Million
Q4 2023

Feb 13, 2024
BUY
$3.95 - $6.58 $125,783 - $209,533
31,844 Added 5.3%
633,204 $3.15 Million
Q3 2023

Nov 13, 2023
BUY
$4.8 - $6.4 $115,036 - $153,382
23,966 Added 4.15%
601,360 $3.04 Million
Q2 2023

Aug 11, 2023
BUY
$5.03 - $9.9 $1.43 Million - $2.82 Million
285,141 Added 97.57%
577,394 $2.9 Million
Q1 2023

May 15, 2023
BUY
$5.68 - $11.99 $71,920 - $151,817
12,662 Added 4.53%
292,253 $1.8 Million
Q4 2022

Feb 13, 2023
BUY
$3.28 - $13.2 $29,966 - $120,595
9,136 Added 3.38%
279,591 $3.69 Million
Q3 2022

Nov 14, 2022
BUY
$2.97 - $5.79 $76,225 - $148,600
25,665 Added 10.48%
270,455 $803,000
Q2 2022

Aug 12, 2022
BUY
$3.05 - $6.68 $40,787 - $89,331
13,373 Added 5.78%
244,790 $893,000
Q1 2022

May 13, 2022
BUY
$4.78 - $8.43 $111,374 - $196,419
23,300 Added 11.2%
231,417 $1.43 Million
Q4 2021

Feb 11, 2022
BUY
$7.76 - $14.35 $185,254 - $342,577
23,873 Added 12.96%
208,117 $1.69 Million
Q3 2021

Nov 12, 2021
BUY
$9.33 - $17.08 $58,956 - $107,928
6,319 Added 3.55%
184,244 $2.75 Million
Q2 2021

Aug 13, 2021
BUY
$4.35 - $12.86 $33,782 - $99,870
7,766 Added 4.56%
177,925 $2.23 Million
Q1 2021

May 12, 2021
BUY
$2.28 - $6.81 $177,637 - $530,573
77,911 Added 84.46%
170,159 $774,000
Q3 2020

Nov 13, 2020
BUY
$1.67 - $4.67 $13,926 - $38,943
8,339 Added 9.94%
92,248 $214,000
Q2 2020

Aug 13, 2020
BUY
$0.65 - $2.6 $42,752 - $171,009
65,773 Added 362.67%
83,909 $168,000
Q2 2019

Aug 14, 2019
BUY
$5.44 - $8.68 $34,533 - $55,100
6,348 Added 53.85%
18,136 $108,000
Q1 2019

May 14, 2019
BUY
$6.8 - $10.08 $80,158 - $118,823
11,788 New
11,788 $87,000

Others Institutions Holding PDSB

# of Institutions
64
Shares Held
4.32M
Call Options Held
253K
Put Options Held
70.4K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $55.8M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email